# Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel

> **NCT01188538** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 40 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Epiduo gel
- **DRUG:** BPO

## Key facts

- **NCT ID:** NCT01188538
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01188538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01188538, "Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01188538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*